C&M Scientific has announced the integration of its operations with Northern Balance, forming a single, unified organisation as the official service arm of the SLS Group under a new name: Labserve. The new brand was unveiled at the Scientific Laboratory Show and Conference 2026, marking a significant milestone in the evolution of laboratory service provision across [...]

Melville, NY -- Today Canon U.S.A., Inc. announced the official North American launch of its groundbreaking Raman plastic analyzer, the TR-A100. The innovative Raman plastic identification equipment is available now, bringing advanced material identification technology to the region. Raman analysis is a non-destructive technique that uses laser light to molecularly identify materials. Widely used across [...]

The new Bengaluru-based platform integrates mass spectrometry-driven workflows with advanced bioanalytical and clinical research capabilities to deliver regulatory‑ready data for global biopharma sponsors. Bengaluru, India — Agilent Technologies, a global leader in analytical and laboratory solutions, today announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory‑aligned analytical and bioanalytical workflows supporting biopharma development, as [...]

Werfen, global leader in specialized diagnostics, has announced a strategic collaboration with Oxford Nanopore Technologies to validate Werfen’s specialized transplant assay portfolios for use on Oxford Nanopore’s sequencing platforms. The collaboration combines Werfen’s validated transplant assays with Oxford Nanopore’s sequencing technology to deliver fast, high-resolution results, essential for precise donor-recipient matching. It also streamlines and [...]

New agentic product helps life science teams evaluate, prioritize, and advance higher-confidence product opportunities ahead of major development investment SOUTH SAN FRANCISCO, Calif. -- Brightseed, Inc., a bio- and AI-native powered innovation platform for life science teams, today announced the launch of Hummingbird™, a new agentic AI product designed to help teams turn biological discovery [...]

Seer defends its pioneering Proteograph® Product Suite intellectual property (IP) REDWOOD CITY, Calif. -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has filed a patent infringement suit against Nanomics Biotechnology Co., Ltd. The asserted patents, U.S. Patent Nos. 11,435,360, 11,630,112, 12,050,222, 12,228,566, and 12,590,948, protect [...]

HOUSTON -- Elabscience® Bionovation Inc. ("Elabscience®" or "the Company") today announced the launch of its self-developed PolyHRP-Streptavidin conjugate, a signal amplification reagent designed to improve enzyme-linked immunosorbent assay (ELISA) sensitivity for low-abundance biomarker detection. Using proprietary covalent polymerization technology, the reagent creates a one-to-many amplification structure that strengthens detection signals while maintaining low background interference. Elabscience® developed its [...]

Agreement strengthens Aurigene's discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with Aurigene Pharmaceutical Services Limited ("Aurigene Services"), an end-to-end integrated global CRDMO [...]

BOSTON -- Stellaromics, Inc., a leader in 3D spatial multi-omics, today announced two key additions to its executive leadership team: Veronica Mankinen as Senior Vice President of Global Commercial Operations and John Leamon, Ph.D., as Senior Vice President of Product Development. These strategic appointments come as the company ramps up the commercial launch of its Pyxa® [...]

New company grows out of ChristianaCare’s Gene Editing Institute to accelerate discovery and innovation WILMINGTON, Del. -- ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of CRISPR gene editing. The software program grew out of the Gene Editing [...]